PATENT CLAIM ANALYSIS

Application Number: 16067046
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "225800"]

Abstract:
A method of treating schizophrenia includes parenterally administering to a subject a pharmacological agent that inhibits presynaptic glutamate release, modulates postsynaptic glutamate response, or both.

Claim (Index 9):
The method of  claim 1 , wherein the pharmacological agent is administered within 48 hours following the subject's first break.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.12
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12793330', '15650912', '14844021', '13810772', '14278573']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7284423527375102
- 35 USC 102 Novelty (BERT): 0.4794539523659361
- Combined Prediction Score: 0.7035435127003528
- Mean Citation Score: 117.438888
- Max Citation Score: 118.14988
- Similarity Product: 77.32015366374493

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test